61
PharmaCompass offers a list of Cetraxate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cetraxate manufacturer or Cetraxate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cetraxate manufacturer or Cetraxate supplier.
PharmaCompass also assists you with knowing the Cetraxate API Price utilized in the formulation of products. Cetraxate API Price is not always fixed or binding as the Cetraxate Price is obtained through a variety of data sources. The Cetraxate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cetraxate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cetraxate, including repackagers and relabelers. The FDA regulates Cetraxate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cetraxate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cetraxate supplier is an individual or a company that provides Cetraxate active pharmaceutical ingredient (API) or Cetraxate finished formulations upon request. The Cetraxate suppliers may include Cetraxate API manufacturers, exporters, distributors and traders.
click here to find a list of Cetraxate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Cetraxate Drug Master File in Japan (Cetraxate JDMF) empowers Cetraxate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Cetraxate JDMF during the approval evaluation for pharmaceutical products. At the time of Cetraxate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Cetraxate suppliers with JDMF on PharmaCompass.
We have 2 companies offering Cetraxate
Get in contact with the supplier of your choice: